title: [Comparative efficacy of sustained release verapamil and captopril in mild to moderate arterial hypertension by ambulatory measurement and occasional measurement].
abstract: The evaluation of mild to moderate hypertension must be carried out under the conditions in which treatments are usually prescribed, i.e., in general practice. After specific training of the physicians in the methods used, we evaluated the efficacy and safety of a new formulation of verapamil by comparing it with a reference drug: captopril. The main assessment criterion was the restoration of normal blood pressure in mildly to moderately hypertensive patients (blood pressure in excess of 160/95 mmHg). Blood pressure was evaluated by two methods: a mercury column sphygmomanometer, after the patient had rested in a half-sitting position for 10 minutes, and the ambulatory measurement of blood pressure (AMBP) using the SpaceLabs system. The results of this study involving 40 patients followed up for 3 months by 8 GPs in collaboration with our blood pressure unit were as follows: on verapamil, 47% of patients recovered normal values after 30 days of treatment and 71% after 60 days (with no change in dosage). On captopril, the normalization rates were 22 and 27% respectively. The highly significant reduction of blood pressure found by the "occasional" measurement for both treatments (p less than 0.001) was only faintly reflected by AMBP. Verapamil induced a reduction of nighttime blood pressure with no significant impact on heart rate. The clinical, paraclinical and electrocardiographic safety of both treatments was good.
authors.affiliation: Laboratoire de Pharmacologie Expérimentale et Clinique, Faculté de Médecine de Nice.
authors.forename: M D
authors.initials: MD
authors.lastname: Drici
authors.forename: B
authors.initials: B
authors.lastname: Teboul
authors.forename: P
authors.initials: P
authors.lastname: Lapalus
authors.forename: P
authors.initials: P
authors.lastname: Morand
authors.forename: J P
authors.initials: JP
authors.lastname: Atlan
authors.forename: J M
authors.initials: JM
authors.lastname: Bouche
authors.forename: J P
authors.initials: JP
authors.lastname: Ceccaldi
authors.forename: S
authors.initials: S
authors.lastname: Giacomoni
authors.forename: G
authors.initials: G
authors.lastname: Halimi
authors.forename: M
authors.initials: M
authors.lastname: Passeron-Seître
mesh_terms: D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D001795:Blood Pressure Determination; D015924:Blood Pressure Monitors; D002216:Captopril / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D004311:Double-Blind Method; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008875:Middle Aged; D014700:Verapamil / Q000627:therapeutic use*
chemical_list: D003692:Delayed-Action Preparations; D002216:Captopril; D014700:Verapamil
vernacular_title: Efficacité comparée du vérapamil à libération prolongée et du captopril dans l'hypertension artérielle légére à modérée par la mesure ambulatoire et mesure "occasionnelle".